Navigation Links
Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More

Former US president Bill Clinton has once again lent a helping hand to HIV/ AIDS victims. After a fallout between the Brazil government and drug giant Merck over pricey anti-retroviral drugs, the Clinton foundation has helped diffuse the situation. Clinching a deal with two Indian pharmaceutical companies Cipla and Matrix, Bill Clinton announced the tie-up with the companies to provide second-line AVR drugs and a next generation one-pill-a-day drug.

Cipla and Matrix agreed to price their drugs on a cost-plus basis and collaborate with Clinton Foundation HIV and AIDS Initiative (CHAI) to lower production costs, in part, by securing lower prices for key raw materials and by addressing major chemistry challenges.

These agreements lower prices for 16 formulations of ARVs, which will be available to 66 developing countries in Africa, Asia, Latin America and the Caribbean through the Clinton Foundations Procurement Consortium, a release from CHAI added.

Bill Clinton was quoted: Seven million people in the developing world are in need of treatment for HIV/AIDS. We are trying to meet that need with the best medicine available today, and at prices that low-and middle-income countries can afford. I applaud Cipla and Matrix for their commitment to lower the cost of new drugs at the forefront of the fight against AIDS, and I thank UNITAID for the funds.

The AIDS virus infects nearly 39 million people globally, and has killed 25 million people since it was identified 25 years ago. Virtually all (95 percent) of people infected with the virus live in the developing world.

Experts say that by the year 2010, nearly half a million people in developing countries will need the drugs which currently cost far more money than the majority of developing countries can afford.

As Clinton was reported saying- companies will not live or die because of high price premiums for AIDS drugs in middle-income countries, but pati ents may.

The former US president states that while he upholds the belief in intellectual property and understands that manufacturers need to earn profits to keep the discovery and supply of AIDS drugs sustainable, that creed should not prevent essential life-saving medicines reaching those who need them in low and middle-income countries.


'"/>




Related medicine news :

1. Clintons new problem - Is the outgoing American president suffering from skin cancer?
2. AIDS testing gets support from Bill Clinton
3. Bill Clinton On A Kill, To Bell The Bulge Out of Schools
4. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
5. Clinton, Gates Highlight Treatment, Discrimination of AIDS
6. Powerful Synergy: Botswana and Clinton foundation To Sign MOU
7. Clinton’s Nutrition Deal Cuts Junk Food on School Menu
8. Bill Clinton Says US Healthcare System Immoral
9. Hillary Clinton Speaks Up Strongly for Stem Cell Research
10. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
11. Kalam To Lay Foundation Of Vellore Research Center
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite ... program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, single-family ... some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average ... extremely low property-tax rates, which contributes to the relatively lower cost of living ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: